Suspected or Proven Clostridioides Difficile Infection Management in Adults (189)


Clostridioides difficile is formerly known as Clostridium difficile

A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments.

Clinical judgement should be exercised on the applicability of any guideline, influenced by individual patient characteristics. Clinicians should be mindful of the potential for harmful polypharmacy and increased susceptibility to adverse drug reactions in patients with multiple morbidities or frailty.

If, after discussion with the patient or carer, there are good reasons for not following a guideline, it is good practice to record these and communicate them to others involved in the care of the patient.


Use the button below to access this item.

Access this resource

Editorial Information

Last reviewed: 27/02/2024

Next review date: 28/02/2027

Author(s): Ysobel Gourlay.

Version: 9

Author email(s):

Approved By: Antimicrobial Utilisation Committee

Reviewer name(s): Ysobel Gourlay.

Document Id: 189